RxDoctor Payments Data

Bethany Sachel, PA

Physician Assistant · West Seneca, NYNPI 1740593425

Payments from drug & device makers

$1,730in general payments, 2019–2025

Across 26 payments — averaging $66.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$386
  • BETA Bionics, Inc.$381
  • Sequel Med Tech, LLC$245
  • Medtronic$218
  • Lilly USA, LLC$152
  • AstraZeneca$148
  • plus $200 from 5 others

What the payments were for

  • Food & beverage$1,69198%
  • Education$392%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,730 in reported general payments places this provider in the 80th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$14,787
Medicare patients
62
Services billed
241

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide150$268,454
JardianceEmpagliflozin130$153,820
TrulicityDulaglutide54$92,696
MounjaroTirzepatide69$88,224
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/746$78,471
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog57$56,142
Humalog Kwikpen U-200Insulin Lispro17$53,484
FarxigaDapagliflozin Propanediol35$49,905
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog28$48,293
Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt15$34,016
EliquisApixaban29$24,239
ProliaDenosumab12$21,512
Humalog Kwikpen U-100Insulin Lispro37$17,757
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$14,942
Levothyroxine Sodium427$7,984

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$386$268,454150 claims
Lilly USA, LLCTrulicity, Mounjaro, Humalog$152$188,718141 claims
AstraZenecaFarxiga$148$49,90535 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in West Seneca

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →